Abound Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Abound Wealth Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$119	–	1512
2026 Q1	$119	Hold	2	–	–	﹤0.01%	1378
2025 Q4	$124	Hold	2	–	–	﹤0.01%	1344
2025 Q3	$125	Hold	2	–	–	﹤0.01%	1270
2025 Q2	$160	Sell	2 -1	-33%	-$84	﹤0.01%	1119
2025 Q1	$258	Hold	3	–	–	﹤0.01%	906
2024 Q4	$235	Hold	3	–	–	﹤0.01%	992
2024 Q3	$217	Sell	3 -3	-50%	-$212	﹤0.01%	1111
2024 Q2	$414	Hold	6	–	–	﹤0.01%	884
2024 Q1	$436	Hold	6	–	–	﹤0.01%	942
2023 Q4	$368	Hold	6	–	–	﹤0.01%	1064
2023 Q3	$344	Hold	6	–	–	﹤0.01%	955
2023 Q2	$357	Buy	+6	New	+$359	﹤0.01%	981

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Abound Wealth Management's PBH Position: Q2 2026 in Review

Abound Wealth Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 2 shares — an estimated $119 sold.

Abound Wealth Management first reported a position in PBH in Q2 2023 and held it in 12 quarters. The position peaked at $436 in Q1 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Abound Wealth Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
Abound Wealth Management sold 2 Prestige Consumer Healthcare shares in Q2 2026, an estimated $119.
Abound Wealth Management first reported a position in Prestige Consumer Healthcare in Q2 2023 and held it in 12 quarters.
Abound Wealth Management's Prestige Consumer Healthcare position peaked at $436 in Q1 2024.
319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.